全文获取类型
收费全文 | 59688篇 |
免费 | 4280篇 |
国内免费 | 547篇 |
专业分类
耳鼻咽喉 | 1073篇 |
儿科学 | 890篇 |
妇产科学 | 1033篇 |
基础医学 | 9371篇 |
口腔科学 | 1569篇 |
临床医学 | 5344篇 |
内科学 | 11171篇 |
皮肤病学 | 1897篇 |
神经病学 | 4375篇 |
特种医学 | 3549篇 |
外科学 | 8291篇 |
综合类 | 450篇 |
现状与发展 | 3篇 |
一般理论 | 18篇 |
预防医学 | 2420篇 |
眼科学 | 1389篇 |
药学 | 5740篇 |
1篇 | |
中国医学 | 807篇 |
肿瘤学 | 5124篇 |
出版年
2023年 | 317篇 |
2022年 | 370篇 |
2021年 | 1967篇 |
2020年 | 1084篇 |
2019年 | 1620篇 |
2018年 | 1832篇 |
2017年 | 1513篇 |
2016年 | 2056篇 |
2015年 | 2865篇 |
2014年 | 3235篇 |
2013年 | 3749篇 |
2012年 | 5460篇 |
2011年 | 5116篇 |
2010年 | 3228篇 |
2009年 | 2663篇 |
2008年 | 3650篇 |
2007年 | 3301篇 |
2006年 | 2972篇 |
2005年 | 2825篇 |
2004年 | 2348篇 |
2003年 | 2024篇 |
2002年 | 1764篇 |
2001年 | 1201篇 |
2000年 | 1162篇 |
1999年 | 932篇 |
1998年 | 375篇 |
1997年 | 335篇 |
1996年 | 279篇 |
1995年 | 226篇 |
1994年 | 207篇 |
1993年 | 179篇 |
1992年 | 364篇 |
1991年 | 328篇 |
1990年 | 293篇 |
1989年 | 276篇 |
1988年 | 240篇 |
1987年 | 189篇 |
1986年 | 182篇 |
1985年 | 145篇 |
1984年 | 124篇 |
1983年 | 90篇 |
1982年 | 77篇 |
1981年 | 72篇 |
1979年 | 113篇 |
1978年 | 84篇 |
1977年 | 71篇 |
1975年 | 87篇 |
1972年 | 84篇 |
1971年 | 95篇 |
1970年 | 70篇 |
排序方式: 共有10000条查询结果,搜索用时 359 毫秒
1.
2.
Michels Guido Horn Rudolf Helfen Andreas Hagendorff Andreas Jung Christian Hoffmann Beatrice Jaspers Natalie Kinkel Horst Greim Clemens-Alexander Knebel Fabian Bauersachs Johann Busch Hans-Jörg Kiefl Daniel Spiel Alexander O. Marx Gernot Dietrich Christoph F. 《Der Anaesthesist》2022,71(4):307-310
Die Anaesthesiologie - 相似文献
3.
4.
Sarina A. Piha-Paul Do-Youn Oh Makoto Ueno David Malka Hyun Cheol Chung Adnan Nagrial Robin K. Kelley Willeke Ros Antoine Italiano Kazuhiko Nakagawa Hope S. Rugo Filippo de Braud Andrea Iolanda Varga Aaron Hansen Hui Wang Suba Krishnan Kevin G. Norwood Toshihiko Doi 《International journal of cancer. Journal international du cancer》2020,147(8):2190-2198
We present data from patients with advanced biliary tract cancer (BTC) receiving pembrolizumab in the KEYNOTE-158 (NCT02628067; phase 2) and KEYNOTE-028 (NCT02054806; phase 1b) studies. Eligible patients aged ≥18 years from both studies had histologically/cytologically confirmed incurable BTC that progressed after standard treatment regimen(s), measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, Eastern Cooperative Oncology Group performance status 0/1, and no prior immunotherapy. Programmed death ligand 1 (PD-L1)-positive tumors were required for eligibility in KEYNOTE-028 only. Patients received pembrolizumab 200 mg every three weeks (KEYNOTE-158) or 10 mg/kg every two weeks (KEYNOTE-028) for ≤2 years. Primary efficacy endpoint was objective response rate (ORR) by RECIST v1.1. Response assessed by independent central review is reported. KEYNOTE-158 enrolled 104 patients and KEYNOTE-028 enrolled 24 patients. Median (range) follow-up was 7.5 months (0.6-34.3) in KEYNOTE-158 and 5.7 months (0.6-55.4) in KEYNOTE-028. In KEYNOTE-158, ORR was 5.8% (6/104; 95% CI, 2.1%-12.1%); median duration of response (DOR) was not reached (NR) (range, 6.2-26.6+ months). Median (95% CI) OS and PFS were 7.4 (5.5-9.6) and 2.0 (1.9-2.1) months. Among PD-L1-expressers (n = 61) and PD-L1-nonexpressers (n = 34), respectively, ORR was 6.6% (4/61) and 2.9% (1/34). In KEYNOTE-028, ORR was 13.0% (3/23; 95% CI, 2.8%-33.6%); median DOR was NR (range, 21.5-53.2+ months). Median (95% CI) OS and PFS were 5.7 (3.1-9.8) and 1.8 (1.4-3.1) months. Grade 3 to 5 treatment-related adverse events occurred in 13.5% of patients in KEYNOTE-158 (no grade 4; grade 5 renal failure, n = 1) and 16.7% in KEYNOTE-028 (no grade 4/5). In summary, pembrolizumab provides durable antitumor activity in 6% to 13% of patients with advanced BTC, regardless of PD-L1 expression, and has manageable toxicity. 相似文献
5.
Kenny P. Pang FRCSEd FRCSI Claudio Vicini MD Filippo Montevecchi MD Ottavio Piccin MD MSc Sudipta Chandra MBBS MS Hyung C. Yang MD PhD Vikas Agrawal MS DLO Joseph C. K. Chung FRCS Yiong H. Chan BSc PhD Scott B. Pang Kathleen A. Pang Edward B. Pang Brian Rotenberg MD MPH FRCSC 《The Laryngoscope》2020,130(9):2281-2284
6.
Autoimmune comorbid diseases associated with lichen planus: a nationwide case–control study 下载免费PDF全文
7.
8.
9.
Jae Yun Ahn Jung Bae Park Sungbae Moon Jae Wan Cho Dong Ho Park 《Ophthalmic epidemiology》2020,27(2):105-114
ABSTRACT
Purpose
Work-related eye injuries have been reported with a variety of epidemiologic and clinical characteristics. We aimed to identify epidemiologic characteristics of work-related eye injuries and risk factors associated with severe injury in a large metropolitan city. 相似文献10.
Ho-Chul Jung Sung-Bin Chon Won Sup Oh Dong-Hyun Lee Ho-Jin Lee 《The American journal of tropical medicine and hygiene》2015,92(2):256-261
Scrub typhus usually presents as acute undifferentiated fever. This cross-sectional study included adult patients presenting with acute undifferentiated fever defined as any febrile illness for ≤ 14 days without evidence of localized infection. Scrub typhus cases were defined by an antibody titer of a ≥ fourfold increase in paired sera, a ≥ 1:160 in a single serum using indirect immunofluorescence assay, or a positive result of the immunochromatographic test. Multiple regression analysis identified predictors associated with scrub typhus to develop a prediction rule. Of 250 cases with known etiology of acute undifferentiated fever, influenza (28.0%), hepatitis A (25.2%), and scrub typhus (16.4%) were major causes. A prediction rule for identifying suspected cases of scrub typhus consisted of age ≥ 65 years (two points), recent fieldwork/outdoor activities (one point), onset of illness during an outbreak period (two points), myalgia (one point), and eschar (two points). The c statistic was 0.977 (95% confidence interval = 0.960–0.994). At a cutoff value ≥ 4, the sensitivity and specificity were 92.7% (79.0–98.1%) and 90.9% (86.0–94.3%), respectively. Scrub typhus, the third leading cause of acute undifferentiated fever in our region, can be identified early using the prediction rule. 相似文献